A Quick Messy Update, Which Path will it take?

Nektar TherapeuticsNASDAQ

תיאור

⋅ 20 מרץ 2019 07:08

A prior chart, a new perspective, added analysis, down or sideways? I see more downside, yet, sideways looks plausible. Upside maybe 20% chance to $42 by June. Enjoy the chart.

עסקה פעילה

⋅ 20 מרץ 2019 15:27

עוד